Anal Sac Adenocarcinoma
Anal sac adenocarcinoma, also known as **apocrine gland anal sac adenocarcinoma (AGASACA)**, is a malignant neoplasm originating from the apocrine glands located within the anal sacs. Due to its potential for local invasion and metastasis, it is an important clinically significant tumor of the anal region in both dogs and cats.
EXPERT OPINION
Etiyoloji
The anal sacs are located between the smooth muscle layer forming the internal anal sphincter and the striated muscle layer forming the external anal sphincter. The inner surface of the anal sacs is lined with stratified squamous epithelium. Apocrine glands are present around these structures in both dogs and cats, while cats also have sebaceous glands.
Anal sac adenocarcinoma originates from the apocrine glands located around the anal sacs. The mechanisms responsible for tumor development are not yet fully understood. Its higher incidence in certain dog breeds suggests that genetic predisposition may play a role in disease development. However, AGASACA can develop in any dog or cat.
Pathophysiology
Anal sac adenocarcinomas are generally locally aggressive tumors with a high metastatic potential. Metastatic spread most commonly occurs first to the regional lymph nodes. The sacral, medial iliac, and internal iliac lymph nodes are particularly important sites for metastatic disease.
As the disease progresses, tumor cells may spread to more distant organs. The liver, lungs, and spleen are among the primary sites where distant metastases may occur.
Therefore, in patients diagnosed with AGASACA, evaluation of the primary tumor alone is not sufficient. Systematic assessment of the regional lymph nodes and distant organs is essential for accurate disease staging and treatment planning.
One of the important paraneoplastic findings that may occur in patients with AGASACA is hypercalcemia. Hypercalcemia most commonly develops as a result of the production of parathyroid hormone-related protein (PTHrP) by tumor cells.
Increased serum calcium levels can reduce the kidneys' response to antidiuretic hormone, resulting in impaired ability to concentrate urine. As hypercalcemia progresses, significant vasoconstriction may develop, which can lead to a reduction in renal blood flow and glomerular filtration rate.
For these reasons, particularly in AGASACA patients with significant hypercalcemia, close monitoring of renal function and regular assessment of serum calcium levels are important components of clinical management.
Contact
You can contact us for any questions or inquiries.
Copyright 2026 © veterinerklinikonkoloji.com
Our Services
Adenoma or Adenocarcinoma
Atypical Lipomatous Tumors
Benign Tumors
Carcinoma
Melanoma
Neuroendocrine Tumors
Round Cell Tumors
Sarcoma